DIRECT. Coronavirus in France: 55,539 new cases, circulation “very … – Linternaute.com

END OF THE LIVE – The director of the Institute of Global Health in Geneva (Switzerland) Antoine Flahault, guest of LCI a few days ago, told the continuous news channel that, for him, to see the peak of the 5th wave around December 15, “or within a few days”, “remains conceivable” and “plausible”. Several indicators lead him to make this analysis of the health situation in France. First, the fact that the R (the number of people infected by 1 patient: above R = 1, the epidemic is progressing) was 1.3 at the end of last week against 1.17 now, indicates that , if the epidemic is still progressing, its increase is less rapid. In addition, if, Thursday, December 9, 17% more people tested positive compared to the previous week, this increase was quite relative: the day before, Wednesday 8, the increase over one week was 24% and, at the beginning last week, by more than 50%. For Antoine Flahault, this means that the highest level of the wave could be reached in the coming days: “Before its highest level, the curve will round off,” he explained.

The risk ? That the number of cases stabilizes at a very high level and that France experiences a plateau, as in the United Kingdom, where “the R has remained around 1 since mid-August”. For the epidemiologist, the only way to avoid such a scenario would be to put in place “strong measures”.

Jean-Louis Teboul, head of the intensive care unit at Bicêtre hospital, said Friday evening on LCI that “we are far from the saturation of a year ago” at the hospital. The professor, on the other hand, was worried about the end of the year: “We fear with the end of the year that there will be new closed beds.”

According to a study, called MyCovid and published in the scientific journal The Lancet Respiratory, it has been shown that infection with microscopic fungi can worsen respiratory distress. With AFP, Professor Jean-Pierre Gangneux, head of the parasitology and mycology laboratory at Rennes University Hospital and study coordinator, specifies: “Invasive aspergillosis is a disease that we know well in hospital in very immunocompromised patients. In recent years, it has been seen in people who have severe influenza with acute respiratory distress syndrome (ARDS), “reports LCI.

Visiting the Strasbourg Christmas market this Friday evening, Jean Castex wanted to defend the health pass. On his Twitter story, the Prime Minister indicated that “It is thanks to the health pass and in strict compliance with the protocol – reinforced this week – that the Strasbourg Christmas market was able to open its doors.”

This Friday, in Brittany, a cluster was identified by the local authorities. Thus, 30 people have tested positive for the coronavirus, reports Ouest France. These infected people all participated in a meal, a tartiflette evening very precisely, organized by a football club in Ille-et-Vilaine. In all, 130 guests took part and are therefore invited to be tested on Thursday, December 16.

This Friday, the Belfort hospital indicated that the members of its staff, not vaccinated on December 15, would not be made redundant, but suspended without pay and without having the possibility of resuming their work.

This Friday evening, the Ministry of Solidarity and Health communicated the latest figures for the coronavirus vaccination on December 10. 52,248,386 first injections were performed. in addition, 13,766,535 booster doses were administered.

A press release sent by the government to Le Parisien indicates that “the Ministry of Solidarity and Health has taken note of the decision of the High Authority for Health of December 9, 2021”. In addition, the ministry, which had planned to order 50,000 doses, explains that “the nature of the contract provides for the triggering of orders only in the event of early authorization for deployment”. And to conclude: “Discussions with the European Medicines Agency (EMA) continue and a European decision concerning the marketing authorization application is expected at the beginning of 2022.”

This Friday; the High Authority for Health, in an opinion, indicated that it did not authorize the use of Molnupriravir treatment early: “The HAS considers that the Lagevrio treatment (Molnupiravir) does not meet the necessary criteria to obtain an authorization The regulator invokes in particular the efficacy results put forward by the laboratory “less good than those of the available treatments: 30% reduction in the risk of progression to the severe form of Covid-19 only (according to the study MOVe-OUT). “

The regional health authorities of Brittany and Normandy have asked all their health establishments to activate their white plan, starting this Friday.

This Friday, December 10, in a press release, the High Authority for Health (HAS) issued an opinion about treatment against the coronavirus. She authorized Evusheld, a preventive treatment based on AstraZenenca monoclonal antibodies. It is intended for people at very high risk.

While vaccination should be open to children from 5 to 11 years old according to the latest speeches by Jean Castex and Olivier Véran on Monday, December 6, the Vaccine Strategy Orientation Council (COSV) specified, in an opinion sent to the authorities , that he recommends that a serological test be carried out before immunizing each child.